ROST
52
2
HES
79
2
AEE
41
-4
OKE
71
-3
KLAC
65
6
BEN
52
10
CL
64
3
ABBV
40
-8
NFLX
59
-2
VNO
60
-3
DRI
48
-12
WAT
53
3
RRC
76
-2
HCP
78
-2
VRSK
40
-2
EL
52
4
NTAP
65
4
WRK
59
3
GS
78
2
FLS
55
3
ROST
52
2
HES
79
2
AEE
41
-4
OKE
71
-3
KLAC
65
6
BEN
52
10
CL
64
3
ABBV
40
-8
NFLX
59
-2
VNO
60
-3
DRI
48
-12
WAT
53
3
RRC
76
-2
HCP
78
-2
VRSK
40
-2
EL
52
4
NTAP
65
4
WRK
59
3
GS
78
2
FLS
55
3
Financhill
Back

Arrowhead Pharmaceuticals Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Sell
30

ARWR
Arrowhead Pharmaceuticals

Last Price:
22.11
Seasonality Move:
3.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!

Arrowhead Pharmaceuticals Price Quote

$22.11
-0.01 (1.1%)
(Updated: April 27, 2024 at 5:53 AM ET)

Arrowhead Pharmaceuticals Key Stats

Sell
30
Arrowhead Pharmaceuticals (ARWR) is a Sell
Day range:
$21.72 - $22.36
52-week range:
$20.67 - $42.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.08
P/B ratio:
17.09%
Volume:
616.2K
Avg. volume:
954.3K
1-year change:
-37.73%
Market cap:
$2.7B
Revenue:
$240.7M
EPS:
$-2.77

How Much Does Arrowhead Pharmaceuticals Make?

Is Arrowhead Pharmaceuticals Growing As A Company?

Arrowhead Pharmaceuticals Stock Price Performance

What Is Arrowhead Pharmaceuticals 52-Week High & Low?

Arrowhead Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arrowhead Pharmaceuticals?

Is Arrowhead Pharmaceuticals Cash Flow Positive?

  • What Is ARWR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$196.2M
  • What Is Arrowhead Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.7M
  • What Is Arrowhead Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $49.4M

Arrowhead Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ARWR return on invested capital is -87.08%
  • What Is Arrowhead Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -37.38%
  • What Is ARWR Return On Equity?
    ROE is a measure of profitability and is -87.08%

Arrowhead Pharmaceuticals Earnings Date & Stock Price

Arrowhead Pharmaceuticals Competitors

Arrowhead Pharmaceuticals Dividend Yield

Data Unavailable

Arrowhead Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -50.26%
Revenue: -94.32% -88.02%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 53.66
Upside from Last Price: 142.61%

Major Shareholders

  • How many ARWR shares are owned by institutional investors?
    128.2M ARWR shares are owned by institutional investors
  • How many ARWR shares are owned by insiders?
    7.8M ARWR shares are owned by insiders